Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00795990 · ClinicalTrials.gov registry record
Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 350
- Enrollment target
NCT00795990: Completed study, sponsored by University of Utah.
NCT00795990 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 350 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00795990 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 350 participants
- Enrollment target
Study Summary
This is a retrospective chart review to look at the timing of using indomethacin and ibuprofen for PDA closure for infants admitted into the NICU of the University of Utah Hospital from 1/2007-8/2008. The purpose is to compare the outcomes of medical intervention in preterm infants if intervention occurs day of life 4 or less, or day of life 5 or greater, with the birthdate being counted as day of life 1.
Primary Outcome
The primary objective is to compare early (day of life 4 or less) versus late (day of life 5) medical treatment of PDA. Data will be collected via a retrospective chart review. Information will be collected on both the use of indomethacin and ibuprofen. Both medications are used as standard of care in the NICU for closure of PDAs.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2008-11 |
| Est. Completion | 2014-11 |
What the finished NCT00795990 record still lists
NCT00795990 is an observational study that tracks outcomes without assigning an intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00795990 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00795990 about?
NCT00795990 is a clinical study titled "Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants". This is a retrospective chart review to look at the timing of using indomethacin and ibuprofen for PDA closure for infants admitted into the NICU of the University of Utah Hospital from 1/2007-8/2008. The purpose is to compare the outcomes of medical intervention in preterm infants if intervention o...
What is the current status of trial NCT00795990?
This trial is currently completed. The enrollment target is 350 participants. The study started on 2008-11. Estimated completion is 2014-11.
Who is sponsoring clinical trial NCT00795990?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia